European Archives - Page 75 of 1138 - European Medical Journal

Psoriasis Treatment Study Confirms Biosimilar Effectiveness

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira.

Evaluation of Antimicrobial Resistance Patterns in Afghanistan

Existing studies reveal alarming levels of AMR in Afghanistan, driven by factors such as self-medication, overuse of antibiotics, and inadequate awareness…

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

Neurodegeneration and Cardiovascular Health: New Insights on Racial Differences

Better heart health cuts neurodegeneration biomarkers by 19% in the elderly, but racial disparities in CVH highlight need for targeted interventions.

AI-Driven Platform Predicts Outcomes in High-Risk Bladder Cancer

Notably, AI-driven models outperformed traditional clinical risk calculators like the EORTC and EAU models.

Apolipoprotein A-I Identified as Protective Factor in COPD

New research has identified a potential causal relationship between lipid metabolism and chronic obstructive pulmonary disease.

Probiotic Mixture Could Reduce Fever Duration in Children with URTIs

A recent study shows probiotics reduce fever duration by two days in children with URTIs, potentially providing a safe treatment option.

What is the Link Between Parkinson’s and Autism? ITSN1 Gene Reveals All

ITSN1 gene variant raises Parkinson’s risk tenfold, with links to autism. Breakthrough study reveals dual neurological threat.

5 minutes with... Prof Alexander Egeberg, LEO Pharma

Prof Alexander Egeberg, Vice President, Head of Global Medical Affairs, LEO Pharma, reveals how the company is tackling unmet needs in dermatology.

19 Mar 2025

Improving Management of Food Allergy

The symposium was held on the final day of the European Academy of Allergy and Clinical Immunology’s (EAACI) Food Allergy and Anaphylaxis…